Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Oxiconazole nitrate cream is effective and safe for treating various fungal skin infections.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Tofacitinib helped a woman regrow hair with no major side effects.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Axitinib treatment turned a man's grey hair back to black.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Adalimumab helped control a child's severe eye disease when other treatments failed.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

MVP treatment is effective and safe for recurrent breast cancer.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.